Article info

other Versions

PDF
Original Article
Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1/2 mutations in a Southeast Asian country

Authors

  • Winston Chew Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Rajesh Babu Moorakonda Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, SingaporeSingapore Clinical Research Institute, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Eliza Courtney Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Hazel Soh Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Shao Tzu Li Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Yanni Chen Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Tarryn Shaw Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, Singapore PubMed articlesGoogle scholar articles
  • John Carson Allen Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore PubMed articlesGoogle scholar articles
  • Dafydd Gareth R Evans Manchester Centre for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Central Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Joanne Ngeow Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore, SingaporeLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, SingaporeOncology Academic Clinical Program, Duke-NUS Medical School, Singapore, SingaporeInstitute of Molecular and Cell Biology, Agency for Science Technology and Research (A*Star), Singapore, Singapore PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joanne Ngeow, Division of Medical Oncology, National Cancer Centre Singapore, Cancer Genetics Service, Singapore 169610, Singapore; joanne.ngeow.y.y{at}singhealth.com.sg
View Full Text

Citation

Chew W, Moorakonda RB, Courtney E, et al
Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1/2 mutations in a Southeast Asian country

Publication history

  • Received September 25, 2017
  • Revised November 23, 2017
  • Accepted December 2, 2017
  • First published December 23, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.